Elisabeth Bjork

Insider Reports History

Entity
Individual
Location
C/O Rocket Pharmaceuticals, Inc., 350 Fifth Avenue, Suite 7530, New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Bjork:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 607 $9.13K $15.04 Sep 26, 2024 Direct

Insider Reports Filed by Elisabeth Bjork

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Sep 26, 2024 1 $0 4 Oct 29, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2024 2 $50K 4 Jun 20, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 22, 2023 2 $50K 4 Jun 26, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2022 2 $49.9K 4 Jun 15, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 14, 2021 2 $50K 4 Jun 16, 2021 Director